nilotinib 60 MG Disintegrating Oral Tablet [Cavhanza]

RxNorm concept 2747516, branded drug (sbd). Prescribable name: CAVHANZA 60 MG Disintegrating Oral Tablet.

RxCUI: 2747516
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2747516 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

nilotinib 662281

Other names

Cavhanza 60 MG Disintegrating Oral Tablet

Related concepts

nilotinib 60 MG (SCDC, consists of)
nilotinib 60 MG [Cavhanza] (SBDC, consists of)
Disintegrating Oral Tablet (DF, has dose form)
Cavhanza (BN, has ingredient)
nilotinib 60 MG Disintegrating Oral Tablet (SCD, tradename of)

Linked data

NDCs

70709019112

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2747516 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2747516 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2747516. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.